ABSTRACT We have cloned the uvrC gene of Escherichia coli, using an F' plasmid carrying the uvrC region as a source of DNA. Two plasmids, pSC1O1 and pBR322, were used as cloning vectors. The recombinant plasmids were selected for their ability to complement the uvrC defect ofE. coli strains AB1884 and N177. We conclude that the uvrC structural gene is contained in a 1.9-kilobase DNA fragment. The protein encoded by the uvrC gene appears to have a monomer molecular weight of 64,500 as analyzed by denaturing polyacrylamide gel electrophoresis. Strains containing multicopy uvrC' plasmids overproduce a factor that is missing in lysates of uvrC-mutants and required for an in vitro model repair reaction. The expression of uvrC' hybrid plasmids suggests that the structural gene is separated by at least 0.8 kilobase from the regulatory region.
Excision repair of DNA is postulated to proceed by recognition of damage, cleavage at the site of damage (termed "incision"), excision ofthe damage, resynthesis, and religation. These steps are a minimum after ultraviolet irradiation (UV) and some steps, such as incision, may require the coordinated action of several gene products. The uvrC-mutants of Escherichia coli are UV sensititive and are defective in excision repair, as are uvrA-and uvrB-mutants (1) . Although the uvrA and uvrB products have been implicated in the initial step(s) required for strand scission at the site of damage prior to excision of pyrimidine dimers (2, 3) , the function ofthe uvrC gene product is not understood. We have reported normal repair incision in permeable uvrC( cells (4) , in contrast to other reports (5) . This led us to postulate a postincision function for uvrC, in agreement with early in vivo observations (6) . The uvrC product may act in a concerted response with the uvrA and uvrB factors to promote incisions. Repair proteins including the uvrC gene product have been isolated from wild-type E. coli (7) , but low levels of the uvrA, uvrB, and uvrC gene products within cells has precluded satisfactory characterization. Lack ofan adequate in vitro assay for the uvrC function has further hampered characterization.
We have employed gene cloning to amplify the uvrC gene and to facilitate purification of its gene product. The cloning of the uvrC gene also should be a direct approach to understanding its regulation and the identification ofthe protein(s) its specifies. In this report, we describe the cloning and expression of the uvrC gene in hybrid plasmid vectors. The uvrC structural gene is present on a 1.9-kilobase (kb) fragment of E. coli DNA and encodes a protein with a monomer molecular weight of 64,500. Analysis ofcomplementing and noncomplementing hybrid plasmids indicates that the regulatory regions for the uvrC gene are at some distance from the structural gene. Our previous results from in vitro analysis of single-strand DNA breaks in UV-irradiated cells have suggested that the uvrC-mutants are not defective at the incision step, but they fail to excise dimers and do not allow repair synthesis (4) . Postincision functions are needed for repair synthesis, and the uvrC function, which is present at increased levels in strains containing uvrC' plasmids, fulfills such a requirement. We have used our observations to design an in vitro assay for the uvrC activity.
MATERIALS AND METHODS Materials. Cesium chloride was purchased from Schwarz/ Mann. Ethidium bromide, agarose, acrylamide, and Dowex AG50W-X8 were obtained from Bio-Rad. Ampicillin, tetracycline, chloramphenicol, lysozyme, and dimethyl sulfoxide were purchased from Sigma. Restriction endonucleases were purchased from Bethesda Research Laboratories (Rockville, MD) and New England BioLabs. Growth media were purchased from Difco. Kodak supplied the x-ray films (XR-5). 2,5-Diphenyloxazole for fluorography purposes was purchased from New England Nuclear. Phage T4 ligase was obtained from Worthington. Micrococcus luteus UV-endonuclease was prepared in our laboratory as described (8) .
Bacterial Strains, Plasmids, and Growth Conditions. Bacterial strains used in this study were AB1884 uvrC-(1), N17-7 uvrC-(9), AB1157 wild type (1), AB1885 uvrB-(1), N3-7 uvrA-(9), and CSR603 uvrA-, recAl, phr-1 (10). JC1553 carries plasmid F150, which covers the E. coli genetic map from eda to his and encompasses the uvrC gene locus (11) .
Bacteria were routinely grown in L broth (LB) liquid culture or on agar plates supplemented with glucose. K9 (12) salts medium was essentially M9 supplemented with 1% casamino acids and 0.2% thiamin. Ampicillin, tetracycline, and streptomycin at 30 Ag/ml, 25 ,ug/ml, and 100 ,ug/ml, respectively, were added to cultures and agar plates when required.
Restriction Microcolony Assay and Analysis of Plasmids. The relative sizes of plasmids in single colonies were determined by microcolony assay (14) . Plasmid DNAs were purified by lysozyme/ Triton X-100 lysis and CsCVethidium bromide gradient centrifugation (15, 16) . The size of the restriction fragments was determined relative to A DNA standards on 1% aragose gels (17) .
Labeling ofPlasmid-Specified Polypeptides in Maxicells and NaDodSO,/Polyacrylamide Gel Electrophoresis. Polypep- tides in maxicells were labeled with [3S]methionine as described by Sancar et al. (18) with the modification that UV-irradiated derivatives of CSR603 (recAl, uvrA6, phr-1) containing plasmids were treated with cycloserine (100 ,g/ml) twice, after 1 hr and 5 hr of irradiation. Protein samples were prepared and subjected to 10% NaDodSO4/polyacrylamide gel (30:1 acrylamide/bisacrylamide) electrophoresis as described by Laemmli and Mavre (19) . The destained gel was treated with 2,5-diphenyloxazole for fluorography (20) . RESULTS Cloning of the uvrC Gene. The F'-150 plasmid carrying genes for uvrC, lipid metabolism (pgsA), flaB, flaD, his, and other markers (11) was the source of DNA for cloning the uvrC gene. We used F'-150 to enrich for the uvrC gene in this work on the basis ofthe following observations: (i) pgsA-strains transformed with F'-150 and selected in minimal medium lacking histidine showed phosphatidylglycerophosphate synthase (pgsA) activity (17); (ii) the pgsA locus and the uvrC locus lie within approximately 0.2 minutes on the E. coli genetic map; (iii) a restriction enzyme analysis of a DNA fragment from F'-150 inserted into pSC101 and complementing pgsA and uvrC genes agrees with part of the restriction analysis of pLC13-12, a plasmid derived from the Clarke and Carbon collection (21) , which carries flaD and uvrC but lacks the pgsA gene (22) .
To exclude the possibility of cell mortality due to the overproduction of products of the uvrC or adjacent genes, we used a low copy number plasmid pSC101 (carrying a gene for tetracycline resistance) for initial cloning. When a mixture of F'-150 (=150 kb) and pSC101 (9.6 kb) DNA (14) . We obtained four different stable plasmids conferring UV resistance ( Fig. 1) : pUVL, pUV3, pUV7, and pUV8.
Presence of the uvrC Gene in a 1.9-kb DNA Fragment. Plasmid DNA from UV-resistant transformants was isolated and analyzed by gel electrophoresis before and after digestion with restriction endonucleases HindIII, BamHI, and Bgl II. Fig. 1 shows composite restriction maps of hybrid plasmids with respect to the original uvrC plasmid, pPG1, and complementing activity. The four plasmids conferring normal UV resistance-pUVl, pUV3, pUV7, and pUV8-contained patterns unique to chromosomal DNA in pPG1 and different from pBR322. A common feature associated with these hybrid plasmids was the presence of a 1.9-kb DNA fragment (Bgl II-Bgl II fragment in pPG1). The location ofthe uvrC gene in this fragment was confirmed by inserting the HindIII-HindIII fragment of pUV8 into pBR322 and subcloning. This plasmid, pUV201, complemented the UV sensitivity ofAB1884 (uvrC-) cells. The analysis of pPGLA1 and pUV16, which have deletions in the region ofBgl II-Bgl II and do not complement the uvrC defect, confirmed our conclusion that the uvrC gene is in the 1.9-kb fragment. It is important to note that plasmid pUV704, derived from pUV7 by deleting the Bam HI-Bgl II (2.4-kb) fragment, but still containing the 1.9-kb fragment, does not complement the uvrC defect. This result could be explained if the E. coli promoter for the uvrC gene were present in the BamHI-Bgl II (2.4-kb) fragment of pUV7. The HindIII-HindIII fragment of pUV7, containing 0.8 kb in addition to the 1.9 kb, does not complement the uvrC defect (pUV301), so the regulatory region lies some distance (at least 0. 8 kb) from the 1. 9-kb fragment. Because both pUV201 and pUV704 contain the 1.9-kb fragment only, and both contain the tetracycline promoter, it seems that the orientation ofthe structural gene is not proper in pUV704, but that in pUV201 the orientation is proper and the tetracycline promoter can fulfill the function of the usual E. coli regulatory region.
Characterization of uvrC' Hybrid Plasmids by Genetic Complementation. The plasmids described above were tested for their ability to restore the UV-resistant phenotype to AB1884 (uvrC-) cells by quantitative testing (Fig. 2) . A wildtype strain, AB1157, transformed with pBR322 shows normal UV resistance over the dose range used in this study, whereas AB1884/pBR322 is highly sensitive to UV. The dose curves in Fig. 2 verify the restoration of survival to uvrC-mutants by plasmids selected initially by streak test. Results shown in Fig.2A demonstrate that cloned E. coli DNA, not plasmid pBR322 DNA, is responsible for the restoration of the UV-resistant character to uvrC-mutants.
We have tested N17-7, another uvrC-strain, transformed with our uvrC' hybrid plasmids, for UV survival. We obtained results similar to those presented above for AB1884. Our hybrid plasmids were unable to confer UV resistance to uvrA-and uvrB-cells (Fig. 2B) .
Expression ofProteins Encoded by uvrC+ Hybrid Plasmids. To investigate the proteins encoded by our hybrid plasmids, we transformed strain CSR603 with various hybrid plasmids and analyzed the protein products by the maxicell technique of Sancar et al (18) . Fig. 3 Biochemistry: Sharma et al mature forms of(-lactamase). The uvrC' hybrid plasmids encoded a unique protein with a monomer molecular weight of 64,500 in addition to products associated with pBR322. Plasmid pPG1 also stimulated incorporation into polypeptides of molecular weights 37,000, 33,000, 30,000, 26,000, and 24,000. Previous studies have shown that the polypeptide of molecular weight 24,000 is probably the phosphatidylglycerophosphate synthase protein encoded by the pgsA gene (24) . To confirm our findings, we tested pPG1A1 (lane c), pUV16 (lane e), and pUV704 (lane h), which do not complement uvrC-mutants. These plasmids were found to carry out the synthesis ofpBR322-encoded polypeptides and polypeptides encoded by DNA in pPG1, but did not synthesize a peptide of 64,500 molecular weight. We conclude that the 64,500 molecular weight polypeptide is unique to the uvrC gene and that the product is overproduced in strains containing the gene on a multicopy plasmid. A polypeptide of 64,500 molecular weight would require approximately 1.8 kb for structural sequence. There would be no coding sequences adequate for other polypeptides detectable by this gel system, in the absence of overlapping genes. This is in agreement with the data from pUV201.
Amplified uvrC Activity. Our previous work (4) led us to conclude that the uvrC function acts after incision at the site of damage. In its absence there is no repair synthesis or excision in an in vitro system. Accordingly we have developed a system for coupling DNA synthesis to action ofthe uvrC function at the repair site, an approach we have been able to use on DNA damaged by bleomycin, coupling synthesis via exonuclease III action (25 
